Home » Stocks » CAH

Cardinal Health, Inc. (CAH)

Stock Price: $59.38 USD -0.61 (-1.02%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $59.54 +0.16 (0.27%) Jul 30, 7:30 PM
Market Cap 17.23B
Revenue (ttm) 156.57B
Net Income (ttm) 1.15B
Shares Out 292.00M
EPS (ttm) 3.91
PE Ratio 15.20
Forward PE 9.65
Dividend $1.94
Dividend Yield 3.27%
Trading Day July 30
Last Price $59.38
Previous Close $59.99
Change ($) -0.61
Change (%) -1.02%
Day's Open 59.99
Day's Range 59.15 - 60.38
Day's Volume 4,612,070
52-Week Range 43.07 - 61.93

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

You can combine high-quality companies with mega-trends that are favorable for long-term growth with these dividend healthcare stocks. The post 3 Healthcare Stocks for Dividend Growth appeared first on ...

Other stocks mentioned: BDX, MDT
5 days ago - InvestorPlace

Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may j...

Other stocks mentioned: ABC, JNJ, MCK
1 week ago - Zacks Investment Research

States announce $26 billion settlement to resolve opioid lawsuits: RPT

YouTube video

Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news o...

Other stocks mentioned: ABC, JNJ, MCK
1 week ago - Yahoo Finance

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a compreh...

Other stocks mentioned: ABC, MCK
1 week ago - Business Wire

The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic,...

Other stocks mentioned: ABC, MCK
1 week ago - New York Post

NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in t...

Other stocks mentioned: ABC, MCK
1 week ago - Reuters

McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) have agreed to pay up to $1.179 billion to settle claims by New York state and two of its bigges...

Other stocks mentioned: ABC, MCK
1 week ago - Benzinga

CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have agreed to pay up to $1.179 billion in a settlemen...

Other stocks mentioned: ABC, MCK
1 week ago - Business Wire

Cardinal Health (CAH) launches NavixRx Compliance Packaging and E-Commerce Storefront to allow independent pharmacists to expand services and support medication adherence.

1 week ago - Zacks Investment Research

DUBLIN, Ohio, July 15, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched two new innovative solutions – Cardinal HealthTM NavixRxTM Compliance Packaging and E-Commerce Storefront – to help...

2 weeks ago - PRNewsWire

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain fro...

Other stocks mentioned: MCK, WST
2 weeks ago - Zacks Investment Research

The Dividend Champions are a collection of companies whose only requirement for membership is that they have paid a growing dividend for at least 25 years. While some dividend growth indexes have additi...

Other stocks mentioned: CTBI, KO
3 weeks ago - GuruFocus

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.

1 month ago - Zacks Investment Research

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer...

Other stocks mentioned: ABBV, ABC, CVS, ENDP, JNJ, MCK, RAD ...
1 month ago - Benzinga

Retail investors looking for cheap stocks for the second half of 2021 could benefit from researching these seven equities. The post 7 Cheap Stocks to Buy Now While They're Still Cheap appeared first on ...

Other stocks mentioned: CE, HPQ, KR, MS, SRE, XSD
1 month ago - InvestorPlace

DUBLIN, Ohio, June 24, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of tradin...

1 month ago - PRNewsWire

They have all been consistently raising their payouts for more than a decade.

Other stocks mentioned: CMCSA, MCD
1 month ago - The Motley Fool

DUBLIN, Ohio, June 17, 2021 /PRNewswire/ -- In response to Ohio Governor Mike DeWine's request that business leaders help increase vaccination rates, four Ohio Managed Care Organizations (MCOs) are part...

1 month ago - PRNewsWire

Cardinal Health's (CAH) Nuclear & Precision Health Solutions receive FDA approval for LYMPHOSEEK injection.

1 month ago - Zacks Investment Research

DUBLIN, Ohio, June 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specific...

1 month ago - PRNewsWire

DUBLIN, Ohio, June 3, 2021 /PRNewswire/ -- Four years after the approval of the first CAR-T cell therapies, oncologists are referring more patients for treatment and becoming more comfortable with the c...

1 month ago - PRNewsWire

The lowest yield on this list is 2.9%.

Other stocks mentioned: PEP, TU
1 month ago - The Motley Fool

They're not exactly names you think of for income, but that doesn't make them bad income options.

Other stocks mentioned: FHN, AVGO
2 months ago - The Motley Fool

DUBLIN, Ohio & INDIANAPOLIS--(BUSINESS WIRE)--Cardinal Health and Telix launch Gallium Awareness campaign with release of White-Paper: “Moving beyond the Myth”

2 months ago - Business Wire

Stock valuations are in the clouds, but several Dividend Aristocrats can be had at cheaper prices than their blue-chip peers.

Other stocks mentioned: ADM, AFL, AMCR, ATO, BEN, CINF, ED ...
2 months ago - Kiplinger

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.

2 months ago - Zacks Investment Research

As investors await the Fed minutes to be released Wednesday amid massive consumer earnings cues, make the most of this market with today's Top Buys from Q.ai's artificial intelligence.

Other stocks mentioned: ENR, KWR, LECO, OSK
2 months ago - Forbes

DUBLIN, Ohio, May 14, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes du...

2 months ago - PRNewsWire

These low-cost stocks will provide generous payouts to income investors.

Other stocks mentioned: TMUS
2 months ago - The Motley Fool

Cardinal Health projected making capital expenditures in this fiscal year of between $400 million and $450 million; these investments will be primarily for information technology and infrastructure. On ...

2 months ago - Forbes

Cardinal Health (NYSE: CAH) reported the third-quarter FY21 adjusted EPS of $1.53, which missed the consensus estimate of $1.55. The earnings dropped 6% Y/Y, reflecting a higher non-GAAP effective tax r...

2 months ago - Benzinga

Cardinal (CAH) delivered earnings and revenue surprises of -3.16% and -1.78%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Cardinal Health's (CAH) fiscal third-quarter results reflect weakness in Pharmaceutical segment.

2 months ago - Zacks Investment Research

DUBLIN, Ohio, May 6, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter G...

2 months ago - PRNewsWire

On Thursday, May 06, Cardinal Health (NYSE:CAH) will release its latest earnings report. Here is Benzinga's outlook for the company.

2 months ago - Benzinga

Cardinal Health's (CAH) fiscal third-quarter results are likely to reflect solid performance in Pharmaceutical segment.

2 months ago - Zacks Investment Research

DUBLIN, Ohio, April 27, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launches Outcomes™, a digital ecosystem connecting pharmacists, payers and pharmaceutical companies to mitigate the challen...

3 months ago - PRNewsWire

This podcast is brought to you by Ryder, the only fully integrated logistics & transportation provider in the industry. Ryder's solutions cover the entire supply chain including warehousing, transportat...

3 months ago - FreightWaves

The contract should help Cardinal Health (CAH) provide critical pandemic support in partnership with the U.S. government.

3 months ago - Zacks Investment Research

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

3 months ago - Zacks Investment Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.

3 months ago - Zacks Investment Research

DUBLIN, Ohio, April 13, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HH...

3 months ago - PRNewsWire

Cardinal Health (CAH) Specialty Solutions' newly launched Navista TS will help community oncologists to improve patient care and become successful in value-based care while reducing costs.

3 months ago - Zacks Investment Research

DUBLIN, Ohio, April 7, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to hel...

3 months ago - PRNewsWire

You can't stop it, but you can give yourself a chance of keeping up with inflation.

Other stocks mentioned: SYY, UNP
3 months ago - The Motley Fool

You can diversify and enjoy yields as high as 4.5% with these long-term investments.

Other stocks mentioned: CM, IIPR
4 months ago - The Motley Fool

DUBLIN, Ohio, March 30, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New Yor...

4 months ago - PRNewsWire

With March almost over, many investors are looking to the second quarter and beyond.

Other stocks mentioned: ABBV, CVX, T, WBA
4 months ago - 24/7 Wall Street

Cardinal Health (CAH) is witnessing an uptrend in its stock price, prompted by robust performance in both Pharmaceutical and Medical segments during the fiscal second quarter.

4 months ago - Zacks Investment Research

About CAH

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to pharmaceu... [Read more...]

Industry
Medical Distribution
Founded
1979
CEO
Michael Kaufmann
Employees
48,000
Stock Exchange
NYSE
Ticker Symbol
CAH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 19 analysts, the average rating for CAH stock is "Buy." The 12-month stock price forecast is 63.36, which is an increase of 6.70% from the latest price.

Price Target
$63.36
(6.70% upside)
Analyst Consensus: Buy